These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

789 related items for PubMed ID: 28477681

  • 1. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M, Foo H, Chander RJ, Wen MC, Au WL, Sitoh YY, Tan L, Kandiah N.
    J Neurol Sci; 2017 Jun 15; 377():122-126. PubMed ID: 28477681
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease.
    Wen MC, Ng A, Chander RJ, Au WL, Tan LC, Kandiah N.
    Parkinsonism Relat Disord; 2015 May 15; 21(5):483-8. PubMed ID: 25753847
    [Abstract] [Full Text] [Related]

  • 3. Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.
    Petrou M, Davatzikos C, Hsieh M, Foerster BR, Albin RL, Kotagal V, Müller ML, Koeppe RA, Herman WH, Frey KA, Bohnen NI.
    Acad Radiol; 2016 May 15; 23(5):577-81. PubMed ID: 26874576
    [Abstract] [Full Text] [Related]

  • 4. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT.
    Brain; 2015 Oct 15; 138(Pt 10):2974-86. PubMed ID: 26173861
    [Abstract] [Full Text] [Related]

  • 5. Grey matter atrophy in cognitively impaired Parkinson's disease.
    Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.
    J Neurol Neurosurg Psychiatry; 2012 Feb 15; 83(2):188-94. PubMed ID: 21890574
    [Abstract] [Full Text] [Related]

  • 6. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J, Marecek R, Klobusiakova P, Balazova Z, Anderkova L, Nemcova-Elfmarkova N, Rektorova I.
    Brain Topogr; 2019 Jan 15; 32(1):142-160. PubMed ID: 30206799
    [Abstract] [Full Text] [Related]

  • 7. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
    Duncan GW, Firbank MJ, Yarnall AJ, Khoo TK, Brooks DJ, Barker RA, Burn DJ, O'Brien JT.
    Mov Disord; 2016 Jan 15; 31(1):103-10. PubMed ID: 26202802
    [Abstract] [Full Text] [Related]

  • 8. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
    Ham JH, Lee JJ, Sunwoo MK, Hong JY, Sohn YH, Lee PH.
    Parkinsonism Relat Disord; 2016 Mar 15; 24():95-9. PubMed ID: 26776568
    [Abstract] [Full Text] [Related]

  • 9. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M, Agosta F, Canu E, Copetti M, Magnani G, Marcone A, Pagani E, Balthazar ML, Comi G, Falini A, Filippi M.
    J Alzheimers Dis; 2015 Mar 15; 47(4):995-1007. PubMed ID: 26401778
    [Abstract] [Full Text] [Related]

  • 10. Altered functional connectivity in the default mode network is associated with cognitive impairment and brain anatomical changes in Parkinson's disease.
    Lucas-Jiménez O, Ojeda N, Peña J, Díez-Cirarda M, Cabrera-Zubizarreta A, Gómez-Esteban JC, Gómez-Beldarrain MÁ, Ibarretxe-Bilbao N.
    Parkinsonism Relat Disord; 2016 Dec 15; 33():58-64. PubMed ID: 27659747
    [Abstract] [Full Text] [Related]

  • 11. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y, Nie K, Huang B, Mei M, Guo M, Xie S, Huang Z, Wang L, Zhao J, Zhang Y, Wang L.
    Neurosci Lett; 2017 Sep 29; 658():121-132. PubMed ID: 28823894
    [Abstract] [Full Text] [Related]

  • 12. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M, Canu E, Donzuso G, Stojkovic T, Basaia S, Stankovic I, Tomic A, Markovic V, Petrovic I, Stefanova E, Kostic VS, Agosta F.
    Mov Disord; 2020 Nov 29; 35(11):1987-1998. PubMed ID: 32886420
    [Abstract] [Full Text] [Related]

  • 13. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK, Jeon S, Ham JH, Hong JY, Lee JE, Lee JM, Sohn YH, Lee PH.
    Eur J Neurol; 2014 Jun 29; 21(6):922-e50. PubMed ID: 24661277
    [Abstract] [Full Text] [Related]

  • 14. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease.
    Foo H, Mak E, Yong TT, Wen MC, Chander RJ, Au WL, Tan L, Kandiah N.
    Parkinsonism Relat Disord; 2016 Oct 29; 31():34-40. PubMed ID: 27397577
    [Abstract] [Full Text] [Related]

  • 15. White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy.
    Rektor I, Svátková A, Vojtíšek L, Zikmundová I, Vaníček J, Király A, Szabó N.
    PLoS One; 2018 Oct 29; 13(1):e0187939. PubMed ID: 29304183
    [Abstract] [Full Text] [Related]

  • 16. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson's disease.
    Inguanzo A, Sala-Llonch R, Segura B, Erostarbe H, Abos A, Campabadal A, Uribe C, Baggio HC, Compta Y, Marti MJ, Valldeoriola F, Bargallo N, Junque C.
    Parkinsonism Relat Disord; 2021 Jan 29; 82():16-23. PubMed ID: 33227683
    [Abstract] [Full Text] [Related]

  • 17. [Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].
    Chen HM, Zhang MM, Wang YL.
    Zhonghua Yi Xue Za Zhi; 2020 Nov 24; 100(43):3397-3401. PubMed ID: 33238668
    [Abstract] [Full Text] [Related]

  • 18. Freezing of gait in Parkinson's disease: gray and white matter abnormalities.
    Pietracupa S, Suppa A, Upadhyay N, Giannì C, Grillea G, Leodori G, Modugno N, Di Biasio F, Zampogna A, Colonnese C, Berardelli A, Pantano P.
    J Neurol; 2018 Jan 24; 265(1):52-62. PubMed ID: 29128929
    [Abstract] [Full Text] [Related]

  • 19. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW, Han YH, Mun CW, Chung EJ, Kim EG, Ji KH, Seo JH, Kim SJ.
    J Neurol Sci; 2014 Dec 15; 347(1-2):210-3. PubMed ID: 25451006
    [Abstract] [Full Text] [Related]

  • 20. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM, Dos Santos C, Fullard M, Scordia C, Weintraub D, Erus G, Rosenthal L, Davatzikos C, McMillan CT.
    Eur J Neurol; 2019 Feb 15; 26(2):246-e18. PubMed ID: 30169897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.